Concepedia

Bei Zhang

BZ

Statistics

Publications

30

Citations

1.2K

H-Index

18

Active since

2009

Affiliations

University of Kentucky(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Shanghai Institute of Pharmaceutical Industry

Xuzhou Medical College

Fudan University

Bei Zhang is an author at University of Kentucky specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2009–2023

30

Publications

30

Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

Tesfaye Biftu, Ranabir SinhaRoy, Ping Chen et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment

John C. Gensel, Timothy J. Kopper, Bei Zhang et al. · Scientific Reports · 2017 · 149 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Improvement of emulsifying properties of oat protein isolate–dextran conjugates by glycation

Bei Zhang, Xiao‐Na Guo, Ke‐Xue Zhu et al. · Carbohydrate Polymers · 2015 · 121 citations

Agriculture, Food Science, Pharmaceutical Biotechnology +10

Acute inflammatory profiles differ with sex and age after spinal cord injury

Andrew N. Stewart, John L. Lowe, Ethan P. Glaser et al. · Journal of Neuroinflammation · 2021 · 108 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Transmembrane delivery of anticancer drugs through self-assembly of cyclic peptide nanotubes

Jian Chen, Bei Zhang, Fei Xia et al. · Nanoscale · 2016 · 73 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 30